Large-scale testing (Phase 3)Study completedNCT02127970
What this trial is testing
Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Who this might be right for
AbscessWound InfectionSurgical Site Infection+1 more
Durata Therapeutics Inc., an affiliate of Allergan plc 698